[13]
de Oliveira Felipe, L.; da Silva Júnior, W.F.; de Araújo, K.C.; Fabrino, D.L. Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment. Braz. J. Microbiol., 2018, 49, 212-219.
[21]
Wang, Hong-yan.; Li, Lin.; Li-si, Tan.; Hui-Yuan, Yu.; Jya-Wei, Cheng.; Ya-ping, Pan. Molecular pathways underlying inhibitory effect of antimicrobial peptide Nal-P-113 on bacteria biofilms formation of Porphyromonas gingivalis W83 by DNA microarray. BMC Microbiol., 2017, 17, 1-7.
[60]
Divyashree, M. ShamaPrakash, K.; VeenaShetty, A.; Karunasagar, I. Antibiotic resistance in extended-spectrum beta-lactamase-producing Escherichia coli isolated from effluents of tertiary care hospitals. Int. J. Health Sci. Res., 2015, 5, 27-33.
[66]
Haney, E.F.; Hancock, R.E. Peptide design for antimicrobial and immunomodulatory applications. Peptide Sci., 2013, 100, 572-583.
[71]
Zhao, Y.; Zhang, M.; Qiu, S.; Wang, J.; Peng, J.; Zhao, P.; Zhu, R.; Wang, H.; Li, Y.; Wang, K.; Yan, W.; Wang, R. Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI. AMB Expr, 2016, 6, 122.
[123]
Thomas, S.; Karnik, S.; Barai, R.S.; Jayaraman, V.K. Idicula-Thomas, S. CAMP: A useful resource for research on antimicrobial peptides. Nucleic Acids Res., 2009, 38(1), D774-D780.
[132]
Ren, S.X.; Cheng, A.S.; To, K.F.; Tong, J.H.; Li, M.S.; Shen, J.; Wong, C.C.; Zhang, L.; Chan, R.L.; Wang, X.J.; Ng, S.S. Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. Cancer Res., 2012, 72, 6512-6523.
[133]
Melle, C.; Ernst, G.; Schimmel, B.; Bleul, A.; Thieme, H.; Kaufmann, R.; Mothes, H.; Settmacher, U.; Claussen, U.; Halbhuber, K.J.; von Eggeling, F. Discovery and identification of α-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology, 2005, 129, 66-73.
[134]
Bukurova, I.; Nikitina, S.L.; Khankin, S.L.; Krasnov, G.S.; Lisitsin, N.A.; Karpov, V.L. Identification of protein markers for serum diagnosis of cancer based on microRNA expression profiling. Mol. Biol., 2001, 45, 376-381.
[135]
Ward, D.G.; Roberts, K.; Brookes, M.J.; Joy, H.; Martin, A.; Ismail, T.; Spychal, R.; Iqbal, T.; Tselepis, C. Increased hepcidin expression in colorectal carcinogenesis. World J. Gastroenterol., 2008, 14, 1339.
[136]
Radeva, M.Y.; Jahns, F.; Wilhelm, A.; Glei, M.; Settmacher, U.; Greulich, K.O.; Mothes, H. Defensin alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients. BMC Cancer, 2010, 10, 588.
[137]
Yuen, S.T.; Wong, M.P.; Chung, L.P.; Chan, S.Y.; Cheung, N.; Ho, J.; Leung, S.Y. Up-regulation of lysozyme production in colonic adenomas and adenocarcinomas. Histopathology, 1998, 32, 126-132.
[138]
Wehkamp, J.; Salzman, N.H.; Porter, E.; Nuding, S.; Weichenthal, M.; Petras, R.E.; Shen, B.; Schaeffeler, E.; Schwab, M.; Linzmeier, R.; Feathers, R.W. Reduced Paneth cell α-defensins in ileal Crohn’s disease. PNAS, 2005, 102, 18129-18134.
[139]
Zilbauer, M.; Jenke, A.; Wenzel, G.; Goedde, D.; Postberg, J.; Phillips, A.D.; Lucas, M.; Noble-Jamieson, G.; Torrente, F.; Salvestrini, C.; Heuschkel, R. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Inflamm. Bowel Dis., 2010, 17, 2076-2086.
[140]
Wehkamp, J.; Harder, J.; von Meissner, B.; Herrlinger, K.R.; Stange, E.F.; Fellermann, K.; Schroeder, J.M. Human β-defessin 3: A novel antimicrobial peptide preferentially expressed in ulcerative celitis. Gastroenterology, 2001, 120, A182.
[141]
Monajemi, H.O.U.S.H.E.N.G.; Meenan, J.O.H.N.; Lamping, R.; Obradov, D.O.; Radema, S.A.; Trown, P.W.; Tytgat, G.N.; Van Deventer, S.J. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology, 1996, 110, 733-739.
[142]
Wehkamp, J.; Schwind, B.; Herrlinger, K.R.; Baxmann, S.; Schmidt, K.; Duchrow, M.; Wohlschläger, C.; Feller, A.C.; Stange, E.F.; Fellermann, K. Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins. Dig. Dis. Sci., 2002, 47, 1349-1355.
[143]
Oustamanolakis, P.; Koutroubakis, I.E.; Messaritakis, I.; Malliaraki, N.; Sfiridaki, A.; Kouroumalis, E.A. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 2011, 23, 262-268.
[144]
Cunliffe, R.N.; Kamal, M.; Rose, F.R.A.J.; James, P.D.; Mahida, Y.R. Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J. Clin. Pathol., 2002, 55, 298-304.
[145]
Islam, D.; Bandholtz, L.; Nilsson, J.; Wigzell, H.; Christensson, B.; Agerberth, B.; Gudmundsson, G.H. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med., 2001, 7, 180.
[146]
Hamanaka, Y.; Nakashima, M.; Wada, A.; Ito, M.; Kurazono, H.; Hojo, H.; Nakahara, Y.; Kohno, S.; Hirayama, T.; Sekine, I. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: Antibacterial effect of hBD-2 against Helicobacter pylori. Gut, 2001, 49, 481-487.
[147]
Bauer, B.; Wex, T.; Kuester, D.; Meyer, T.; Malfertheiner, P. Differential expression of human beta defensin 2 and 3 in gastric mucosa of Helicobacter pylori-infected individuals. Helicobacter, 2013, 18, 6-12.
[148]
Jenke, A.C.; Zilbauer, M.; Postberg, J.; Wirth, S. Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis. Pediatr. Res., 2002, 72, 513.
[149]
Harder, J.; Bartels, J.; Christophers, E.; Schroder, J.M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem., 2001, 276, 5707-5713.